DNA
DNA Stock Forecast & Price Target
DNA Analyst Ratings
Based on 1 analyst ratings
Strong Sell
Strong Buy 0%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 100%
DNA has been analyzed by 1 analysts, with a consensus rating of Strong Sell. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 100% predict a Strong Sell.
This aggregate rating is based on analysts' research of Ginkgo Bioworks Holdings and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Ginkgo Bioworks Holdings and is not a guaranteed prediction by Public.com or investment advice.
DNA Analyst Forecast & Price Prediction
Get the latest DNA stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in DNA
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Ginkgo Bioworks Holdings (DNA) Forecast
Analysts have given DNA a Strong Sell based on their latest research and market trends.
According to 1 analysts, DNA has a Strong Sell consensus rating as of Oct 9, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $9, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $9, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.